JP2008514556A - １０ｋＤａ未満の血液成分を含む医薬品ならびに免疫系の障害を予防および処置するためのその使用 - Google Patents

１０ｋＤａ未満の血液成分を含む医薬品ならびに免疫系の障害を予防および処置するためのその使用 Download PDF

Info

Publication number
JP2008514556A
JP2008514556A JP2007532768A JP2007532768A JP2008514556A JP 2008514556 A JP2008514556 A JP 2008514556A JP 2007532768 A JP2007532768 A JP 2007532768A JP 2007532768 A JP2007532768 A JP 2007532768A JP 2008514556 A JP2008514556 A JP 2008514556A
Authority
JP
Japan
Prior art keywords
protein
receptor
kinase
composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007532768A
Other languages
English (en)
Japanese (ja)
Inventor
サラマ，ゾーセル，ベー．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04090376A external-priority patent/EP1640012A1/fr
Priority claimed from US10/948,753 external-priority patent/US20060067942A1/en
Application filed by Individual filed Critical Individual
Publication of JP2008514556A publication Critical patent/JP2008514556A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Rolling Contact Bearings (AREA)
JP2007532768A 2004-09-24 2005-09-26 １０ｋＤａ未満の血液成分を含む医薬品ならびに免疫系の障害を予防および処置するためのその使用 Withdrawn JP2008514556A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04090376A EP1640012A1 (fr) 2004-09-24 2004-09-24 Agents pharmaceutiques comprenant des constituants du sang 10 kDa et l'utilisation dans la prophylaxe et dans le traitement des troubles du système immunitaire
US10/948,753 US20060067942A1 (en) 2004-09-24 2004-09-24 Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals
PCT/DE2005/001729 WO2006032269A2 (fr) 2004-09-24 2005-09-26 Produit pharmaceutique comprenant des acides amines, des peptides, des proteines et/ou leurs fractions et fragments et son utilisation pour la prevention et le traitement de defauts du systeme immunitaire chez l'homme et chez les animaux

Publications (1)

Publication Number Publication Date
JP2008514556A true JP2008514556A (ja) 2008-05-08

Family

ID=36051574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532768A Withdrawn JP2008514556A (ja) 2004-09-24 2005-09-26 １０ｋＤａ未満の血液成分を含む医薬品ならびに免疫系の障害を予防および処置するためのその使用

Country Status (8)

Country Link
EP (1) EP1796695A2 (fr)
JP (1) JP2008514556A (fr)
AU (1) AU2005287727A1 (fr)
BR (1) BRPI0517349A (fr)
CA (1) CA2580192A1 (fr)
DE (1) DE112005002912A5 (fr)
MX (1) MX2007003489A (fr)
WO (1) WO2006032269A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1507215A (en) * 1975-08-19 1978-04-12 Green Cross Corp Processes for producing immunoregulatory preparations
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
ZA847349B (en) * 1983-10-05 1985-04-24 Solco Basel Ag Process for the preparation of a biologically active extract
RU2055589C1 (ru) * 1992-08-21 1996-03-10 Левон Никитович Мкртчян Способ получения биологически активного вещества, обладающего противоопухолевой, иммуномодулирующей и интерфероногенной активностью

Also Published As

Publication number Publication date
MX2007003489A (es) 2007-05-18
WO2006032269A2 (fr) 2006-03-30
EP1796695A2 (fr) 2007-06-20
CA2580192A1 (fr) 2006-03-30
DE112005002912A5 (de) 2007-08-30
AU2005287727A1 (en) 2006-03-30
BRPI0517349A (pt) 2008-10-07
WO2006032269A3 (fr) 2006-06-15

Similar Documents

Publication Publication Date Title
CN109310712A (zh) 用于医学的人血小板裂解物来源细胞外囊泡
EP0247071A1 (fr) Traitement immunotherapeutique.
Mm et al. Encapsulated Hsp70 decreases endotoxin-induced production of ROS and TNFα in human phagocytes
RU2041717C1 (ru) Биологически активное средство, способ его получения и препарат, содержащий указанное средство, и способ использования препарата
JP2003534281A (ja) Ｔ細胞媒介性及び炎症性疾患の治療における使用のためのアポトーシス体
JP2001513636A (ja) ブロメラインの成分
JPH0623113B2 (ja) 癌性胸・腹水貯留抑制剤
ES2915380T3 (es) Procedimiento de producción de una sustancia con actividad antimicrobiana, antiviral e inmunoestimuladora, una sustancia y una composición
JP2008514556A (ja) １０ｋＤａ未満の血液成分を含む医薬品ならびに免疫系の障害を予防および処置するためのその使用
US20080220083A1 (en) Pharmaceutical Agent Comprising Blood Components <10 Kda And Their Use For Prophylaxis And Treatment Of Defects Of The Immune System
FI74475C (fi) Foerfarande foer framstaellning av nya, ur klebsiella pneumoniae extraherade glykoproteiner.
US20060067942A1 (en) Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals
US12053567B2 (en) Method and device for removal of circulating cell free DNA
Abdeltawab et al. Effect of Moringa oleifera and ivermectin nanoparticles on the immunopathological response during experimental trichinosis in mice
JPH06504290A (ja) シュウ酸カルシウム結石病の治療用化合物および医薬組成物
JP2023519700A (ja) ＮＦ－κＢ抑制剤のエキソソーム基盤伝達の使用
US6331403B1 (en) Use of mCRP to slow cell growth and to promote maturation of cells
JP2008514555A (ja) １０，０００ダルトン未満の分子量の白血球ホモジネートを用いた、細胞性免疫不全の治療
JPS6072819A (ja) 細菌毒素の中和剤
US6569465B2 (en) Chemical alteration of mammal urine and mammal blood
JPH03505200A (ja) 治療活性のある、特に傷治療または老人医学に用いる作用物質およびかかる作用物質を含む製剤の製造方法
JPH07504202A (ja) ロイキンフェロン製剤
JPS62249927A (ja) 蛋白物質および抗腫瘍剤
WO2025198027A1 (fr) Kit pour favoriser la traduction en protéine, procédé de production de protéine
JP2002523431A (ja) 物質を細胞内に運搬するためのｍＣＲＰの使用方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080725

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20081020

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090114